Curi Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCuri Bio
Curi Bio logo

Curi Bio

0 followers

About Curi Bio

Curi Bio is a biotechnology company based in Seattle, WA that develops human‑relevant platforms using induced pluripotent stem cell (iPSC)‑derived 2D and 3D tissues. Their products and services focus on mature cardiac, skeletal muscle, and neuromuscular models, as well as biosystem platforms for contractility, voltage, and calcium imaging, complemented by AI/ML‑driven data analytics to accelerate drug discovery, safety, and efficacy testing.

Recent News

Recent Deals

Key Team Members

Greg Luerman, PhD

Vice President, Research & Partnerships

Michael Cho, JD

Chief Strategy Officer and General Counsel

Nicholas Geisse, PhD

Chief Executive Officer

Elliot Fisher

Co-Founder & Chief Business Officer

Key Facts

HQ Location

Seattle, United States

Founded

2015

Employees

11 - 50

Status

Private

Website

https://curibio.com